The publication list is updated every day via PubMed and includes only the most recent articles. A list including only review articles is also available. IDIGH principal investigators are in bold.

CTB

  1. Costiniuk, C. T., Singer, J., Needham, J., Yang, Y., Qian, H., Chambers, C., Burchell, A. N., Samji, H., Colmegna, I., Del Canto, S., Godin, G.-H., Habanyama, M., Hui, C., Kroch, A., Mandarino, E., Margolese, S., Martin, C., Owino, M., Mohammadi, T., Zhang, W., Pelaez, S., Kovacs, C., Benko, E., Vulesevic, B., Cooper, C. L. & Anis, A. H. (2023). Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey. AIDS and behavior.
  2. Razvi, E., Whitfield, G. B., Reichhardt, C., Dreifus, J. E., Willis, A. R., Gluscencova, O. B., Gloag, E. S., Awad, T. S., Rich, J. D., da Silva, D. P., Bond, W., Le Mauff, F., Sheppard, D. C., Hatton, B. D., Stoodley, P., Reinke, A. W., Boulianne, G. L., Wozniak, D. J., Harrison, J. J., Parsek, M. R. & Howell, P. L. (2023). Glycoside hydrolase processing of the Pel polysaccharide alters biofilm biomechanics and Pseudomonas aeruginosa virulence. NPJ biofilms and microbiomes, vol. 9, p. 7.
  3. Zaongo, S. D., Ouyang, J., Isnard, S., Zhou, X., Harypursat, V., Cui, H., Routy, J.-P. & Chen, Y. (2023). Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection. Gut microbes, vol. 15, p. 2167171.
  4. Muntyanu, A., Gabrielli, S., Donovan, J., Gooderham, M., Guenther, L., Hanna, S., Lynde, C., Prajapati, V. H., Wiseman, M. & Netchiporouk, E. (2023). The burden of alopecia areata: a scoping review focusing on quality of life, mental health and work productivity. Journal of the European Academy of Dermatology and Venereology : JEADV.
  5. Adam, D. N., Gooderham, M. J., Beecker, J. R., Hong, C. H., Jack, C. S., Jain, V., Lansang, P., Lynde, C. W., Papp, K. A., Prajapati, V. H., Turchin, I. & Yeung, J. (2023). Expert Consensus on the Systemic Treatment of Atopic Dermatitis in Special Populations. Journal of the European Academy of Dermatology and Venereology : JEADV.
  6. Le Mauff, F. & Sheppard, D. C. (2023). Understanding Aspergillus fumigatus galactosaminogalactan biosynthesis: A few questions remain. Cell surface (Amsterdam, Netherlands), vol. 9, p. 100095.
  7. Royston, L., Isnard, S., Berini, C. A., Bu, S., Lakatos, P. L., Bessissow, T., Chomont, N., Klein, M., Lebouché, B., de Pokomandy, A., Kronfli, N., Costiniuk, C. T., Thomas, R., Tremblay, C., Boivin, G. & Routy, J.-P. (2023). Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study. BMJ open, vol. 13, p. e067640.
  8. Aranguren, M., Doyon-Laliberté, K., El-Far, M., Chartrand-Lefebvre, C., Routy, J.-P., Barril, J.-G., Trottier, B., Tremblay, C., Durand, M., Poudrier, J., Roger, M. & Canadian HIV and Aging Cohort Study (2022). Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals. Vaccines, vol. 11.
  9. Brosseau, N. E., Vallée, I., Mayer-Scholl, A., Ndao, M. & Karadjian, G. (2023). Aptamer-Based Technologies for Parasite Detection. Sensors (Basel, Switzerland), vol. 23.
  10. Charlebois, E., Li, Y., Wagner, V., Pantopoulos, K. & Olivier, M. (2023). Genetic Iron Overload Hampers Development of Cutaneous Leishmaniasis in Mice. International journal of molecular sciences, vol. 24.
  11. Mendel, A., Fritzler, M. J., St-Pierre, Y., Rauch, J., Bernatsky, S. & Vinet, É. (2023). Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study. Research and practice in thrombosis and haemostasis, p. 100041.
  12. Hazlewood, G. S., Colmegna, I., Hitchon, C., Fortin, P. R., Bernatsk, S., Clarke, A. E., Mosher, D., Wilson, T., Thomas, M., Barber, C., Harrison, M., Bansback, N., Proulx, L., Richards, D. P. & Kaplan, G. G. (2023). Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases. The Journal of rheumatology.
  13. Mehdi, A., Attias, M., Arakelian, A., Szyf, M., Piccirillo, C. A. & Rabbani, S. A. (2023). S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas. Neoplasia (New York, N.Y.), vol. 36, p. 100874.
  14. Zhu, C. K., Nguyen, A., Prosty, C., Gabrielli, S., Laboccetta, V., Shand, G., Mulé, P., Netchiporouk, E., Le, M., Zhang, X., Ke, D., Baum, S., Hakroush, R., Greenberger, S. & Ben-Shoshan, M. (2023). Safety of COVID-19 mRNA vaccination in children with chronic urticaria (CU). The journal of allergy and clinical immunology. In practice.
  15. Mehdi, A., Attias, M., Arakelian, A., Piccirillo, C. A., Szyf, M. & Rabbani, S. A. (2022). Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone. Cancers, vol. 15.
  16. Golizeh, M., Nam, J., Chatelain, E., Jackson, Y., Ohlund, L. B., Rasoolizadeh, A., Camargo, F. V., Mahrouche, L., Furtos, A., Sleno, L. & Ndao, M. (2022). New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice. Heliyon, vol. 8, p. e12380.
  17. Guo, S., Lei, X., Chang, Y., Zhao, J., Wang, J., Dong, X., Liu, Q., Zhang, Z., Wang, L., Yi, D., Ma, L., Li, Q., Zhang, Y., Ding, J., Liang, C., Li, X., Guo, F., Wang, J. & Cen, S. (2022). SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. Signal transduction and targeted therapy, vol. 7, p. 400.
  18. Mboumba Bouassa, R.-S., Needham, J., Nohynek, D., Singer, J., Lee, T., Bobeuf, F., Samarani, S., Del Balso, L., Paisible, N., Vertzagias, C., Sebastiani, G., Margolese, S., Mandarino, E., Klein, M., Lebouché, B., Cox, J., Brouillette, M.-J., Routy, J.-P., Szabo, J., Thomas, R., Huchet, E., Vigano, A., Jenabian, M.-A. & Costiniuk, C. T. (2022). Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028). Biomedicines, vol. 10.
  19. Lapointe, H. R., Mwimanzi, F., Cheung, P. K., Sang, Y., Yaseen, F., Speckmaier, S., Barad, E., Moran-Garcia, N., Datwani, S., Duncan, M. C., Kalikawe, R., Ennis, S., Young, L., Ganase, B., Omondi, F. H., Umviligihozo, G., Dong, W., Toy, J., Sereda, P., Burns, L., Costiniuk, C. T., Cooper, C., Anis, A. H., Leung, V., Holmes, D., Demarco, M. L., Simons, J., Hedgcock, M., Prystajecky, N., Lowe, C. F., Romney, M. G., Barrios, R., Guillemi, S., Brumme, C. J., Montaner, J. S. G., Hull, M., Harris, M., Niikura, M., Brockman, M. A. & Brumme, Z. L. (2022). Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART. AIDS (London, England).
  20. An, N., Ge, Q., Shao, H., Li, Q., Guo, F., Liang, C., Li, X., Yi, D., Yang, L. & Cen, S. (2022). Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis. Frontiers in immunology, vol. 13, p. 1007718.
  21. Shah, N., Mustafa, S. S. & Vinh, D. C. (2022). Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology. Critical reviews in oncology/hematology, p. 103896.
  22. Harrison, L. B., Bergeron, G., Cadieux, G., Charest, H., Fafard, J., Levade, I., Blais, A. C., Huchet, E., Trottier, B., Vlad, D., Szabo, J., Thomas, R., Poulin, S., Greenaway, C., Zaharatos, G. J., Oughton, M., Chakravarti, A., Pilarski, R., Bui-Nguyen, A., Benomar, K., Libman, M. D., Vinh, D. C., Duggan, A. T., Graham, M., Klein, M. B. & Barkati, S. (2023). Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak. Annals of internal medicine, vol. 176, p. 67-76.
  23. Doyon-Laliberté, K., Aranguren, M., Byrns, M., Chagnon-Choquet, J., Paniconi, M., Routy, J.-P., Tremblay, C., Quintal, M.-C., Brassard, N., Kaufmann, D. E., Poudrier, J. & Roger, M. (2022). Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection. International journal of molecular sciences, vol. 23.
  24. Costiniuk, C. T., Singer, J., Lee, T., Langlois, M.-A., Arnold, C., Galipeau, Y., Needham, J., Kulic, I., Jenabian, M.-A., Burchell, A. N., Shamji, H., Chambers, C., Walmsley, S., Ostrowski, M., Kovacs, C., Tan, D. H. S., Harris, M., Hull, M., Brumme, Z. L., Lapointe, H. R., Brockman, M. A., Margolese, S., Mandarino, E., Samarani, S., Vulesevic, B., Lebouché, B., Angel, J. B., Routy, J.-P., Cooper, C. L., Anis, A. H. & COVAXHIV Study Group (2023). COVID-19 vaccine immunogenicity in people with HIV. AIDS (London, England), vol. 37, p. F1-F10.
  25. Sarden, N., Sinha, S., Potts, K. G., Pernet, E., Hiroki, C. H., Hassanabad, M. F., Nguyen, A. P., Lou, Y., Farias, R., Winston, B. W., Bromley, A., Snarr, B. D., Zucoloto, A. Z., Andonegui, G., Muruve, D. A., McDonald, B., Sheppard, D. C., Mahoney, D. J., Divangahi, M., Rosin, N., Biernaskie, J. & Yipp, B. G. (2022). A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis. Science translational medicine, vol. 14, p. eabq6682.

 

CORE

  1. Lam, C., Landry, S., Moussa, G., Sakr, D., Varinot, G., Mousseau, K., Martel, D., Frenette, A. J., Ambaraghassi, G., Rouleau, D., Cantarovich, M., Klein, M. B., Sheehan, N. L. & Lemire, B. (2023). Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review. Transplantation direct, vol. 9, p. e1441.
  2. Karim, J., Gabrielli, S., Mule, P., Torabi, B., Byrne, A., De Schryver, S., Gadoury-Lévesque, V., Alizadehfar, R., McCusker, C., Zhang, X. & Ben-Shoshan, M. (2023). Bridging knowledge gaps in paediatric chronic urticaria through a video-based educational tool. Clinical and experimental dermatology, vol. 48, p. 108-111.
  3. Salvadori, M. I., Pucchio, A., Akiva, M. H., Evangeliou, H. & Papenburg, J. (2023). Response to Finsterer and Scorza. Pediatric nephrology (Berlin, Germany), p. 1.
  4. Chambers, C., Deeks, S. L., Sutradhar, R., Cox, J., de Pokomandy, A., Grennan, T., Hart, T. A., Lambert, G., Moore, D. M., Grace, D., Grewal, R., Jollimore, J., Lachowsky, N. J., Mah, A., Nisenbaum, R., Ogilvie, G., Sauvageau, C., Tan, D. H. S., Yeung, A. & Burchell, A. N. (2023). Self-reported Human Papillomavirus Vaccination and Vaccine Effectiveness Among Men Who Have Sex with Men: A Quantitative Bias Analysis. Epidemiology (Cambridge, Mass.), vol. 34, p. 225-229.
  5. Sangaré, M. N., Baril, J.-G., de Pokomandy, A., Klein, M., Thomas, R., Tremblay, C., Pexos, C., Durand, M., Chawla, S., Laporte, L. & Trottier, H. (2023). CD4/CD8 ratio outcome according to the class of the third active drug in antiretroviral therapy (ART) regimens: results from the Quebec Human Immunodeficiency Virus (HIV) Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
  6. Abrahami, D., Pradhan, R., Yin, H., Yanofsky, R., McDonald, E. G., Bitton, A. & Azoulay, L. (2023). Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study. Gut.
  7. Mozafarinia, M., Mate, K. K. V., Brouillette, M.-J., Fellows, L. K., Knäuper, B. & Mayo, N. E. (2023). An umbrella review of the literature on the effectiveness of goal setting interventions in improving health outcomes in chronic conditions. Disability and rehabilitation, p. 1-11.
  8. Zolotarova, T., Dussault, C., Park, H., Varsaneux, O., Basta, N. E., Watson, L., Robert, P., Davis, S., Mercer, M., Timmerman, S., Bransfield, M., Minhas, M., Kempis, R. & Kronfli, N. (2023). Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: The EDUCATE study. Vaccine.
  9. Davar, K., Clark, D., Centor, R. M., Dominguez, F., Ghanem, B., Lee, R., Lee, T. C., McDonald, E. G., Phillips, M. C., Sendi, P. & Spellberg, B. (2023). Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV. Open forum infectious diseases, vol. 10, p. ofac706.
  10. Clarke, A. E., Hanly, J. G., Urowitz, M. B., St Pierre, Y., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M., Ginzler, E. M., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcón, G. S., Van Vollenhoven, R. F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S. S., Inanc, M., Kalunian, K. C., Jacobsen, S., Peschken, C. A., Kamen, D. L., Askanase, A. & Farewell, V. (2023). Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics (SLICC) Cohort using Multistate Modelling. Arthritis care & research.
  11. Royston, L., Isnard, S., Berini, C. A., Bu, S., Lakatos, P. L., Bessissow, T., Chomont, N., Klein, M., Lebouché, B., de Pokomandy, A., Kronfli, N., Costiniuk, C. T., Thomas, R., Tremblay, C., Boivin, G. & Routy, J.-P. (2023). Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study. BMJ open, vol. 13, p. e067640.
  12. Paquette, M., Renaud, C. & Papenburg, J. (2023). Parechovirus infections in infants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 195, p. E121.
  13. Lee, T. C., Almeida, N., Pelletier, P. & McDonald, E. G. (2023). Comparison of Blood Transfusion Rates Before and After Implementation of a Quality Improvement Initiative for Transfusion Safety and Appropriateness. JAMA network open, vol. 6, p. e2252253.
  14. Migowa, A., Bernatsky, S., Ngugi, A., Foster, H. E., Muriuki, P., Lusambili, A. & Luchters, S. (2023). An iceberg I can't handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya. Pediatric rheumatology online journal, vol. 21, p. 6.
  15. Chambers, C., Deeks, S. L., Sutradhar, R., Cox, J., de Pokomandy, A., Grennan, T., Hart, T. A., Lambert, G., Moore, D. M., Grace, D., Grewal, R., Jollimore, J., Lachowsky, N., Nisenbaum, R., Ogilvie, G., Sauvageau, C., Tan, D. H. S., Coutlée, F. & Burchell, A. N. (2023). Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men. The Journal of infectious diseases.
  16. Mendel, A., Fritzler, M. J., St-Pierre, Y., Rauch, J., Bernatsky, S. & Vinet, É. (2023). Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study. Research and practice in thrombosis and haemostasis, p. 100041.
  17. Hazlewood, G. S., Colmegna, I., Hitchon, C., Fortin, P. R., Bernatsk, S., Clarke, A. E., Mosher, D., Wilson, T., Thomas, M., Barber, C., Harrison, M., Bansback, N., Proulx, L., Richards, D. P. & Kaplan, G. G. (2023). Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases. The Journal of rheumatology.
  18. Patel, D., Senecal, J., Spellberg, B., Morris, A. M., Saxinger, L., Footer, B. W., McDonald, E. G. & Lee, T. C. (2023). Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?. JAC-antimicrobial resistance, vol. 5, p. dlac138.
  19. McKenna, L., Frick, M., Angami, K., Dubula, V., Furin, J., Harrington, M., Hausler, H., Heitkamp, P., Herrera, R., Lynch, S., Mitnick, C. D., Moses, G. K., Ndjeka, N., Nyang'wa, B.-T., Palazuelos, L., Ulysse, P. & Pai, M. (2023). The 1/4/6x24 campaign to cure tuberculosis quickly. Nature medicine, vol. 29, p. 16-17.
  20. Zhu, C. K., Nguyen, A., Prosty, C., Gabrielli, S., Laboccetta, V., Shand, G., Mulé, P., Netchiporouk, E., Le, M., Zhang, X., Ke, D., Baum, S., Hakroush, R., Greenberger, S. & Ben-Shoshan, M. (2023). Safety of COVID-19 mRNA vaccination in children with chronic urticaria (CU). The journal of allergy and clinical immunology. In practice.
  21. Al Ali, A., Gabrielli, S., Delli Colli, L., Delli Colli, M., McCusker, C., Clarke, A. E., Morris, J., Gravel, J., Lim, R., Chan, E. S., Goldman, R. D., O'Keefe, A., Gerdts, J., Chu, D. K., Upton, J., Hochstadter, E., Moisan, J., Bretholz, A., Zhang, X., Protudjer, J. L., Abrams, E. M., Simons, E. & Ben-Shoshan, M. (2023). Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends. Expert review of clinical immunology, p. 1-8.
  22. van Santen, D. K., Sacks-Davis, R., Stewart, A., Boyd, A., Young, J., van der Valk, M., Smit, C., Rauch, A., Braun, D. L., Jarrin, I., Berenguer, J., Lazarus, J. V., Lacombe, K., Requena, M.-B., Wittkop, L., Leleux, O., Salmon, D., Bonnet, F., Matthews, G., Doyle, J. S., Spelman, T., Klein, M. B., Prins, M., Asselin, J., Stoové, M. A., Hellard, M. & InCHEHC study group (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, vol. 56, p. 101810.
  23. Mitjà, O., Reis, G., Boulware, D. R., Spivak, A. M., Sarwar, A., Johnston, C., Webb, B., Hill, M. D., Smith, D., Kremsner, P., Curran, M., Carter, D., Alexander, J., Corbacho, M., Lee, T. C., Hullsiek, K. H., McDonald, E. G., Hess, R., Hughes, M., Baeten, J. M., Schwartz, I., Metz, L., Richer, L., Chew, K. W., Daar, E., Wohl, D. & Dunne, M. (2023). Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials. Clinical and translational science.
  24. Yea, C., Barton, M., Bitnun, A., Morris, S. K., El Tal, T., Ulloa-Gutierrez, R., Brenes-Chacon, H., Yock-Corrales, A., Ivankovich-Escoto, G., Soriano-Fallas, A., Hernandez-de Mezerville, M., Gill, P., Nateghian, A., Aski, B. H., Manafi, A. A., Dwilow, R., Bullard, J., Papenburg, J., Scuccimarri, R., Lefebvre, M.-A., Cooke, S., Dewan, T., Restivo, L., Lopez, A., Sadarangani, M., Roberts, A., Wong, J., Saux, N. L., Bowes, J., Purewal, R., Lautermilch, J., Foo, C., Merckx, J., Robinson, J., Yeh, E. A. & Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) (2023). Neurological involvement in hospitalized children with SARS-CoV-2 infection: a multinational study. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, p. 1-10.
  25. Zalla, L. C., Cole, S. R., Eron, J. J., Adimora, A. A., Vines, A. I., Althoff, K. N., Silverberg, M. J., Horberg, M. A., Marconi, V. C., Coburn, S. B., Lang, R., Williams, E. C., Gill, M. J., Gebo, K. A., Klein, M., Sterling, T. R., Rebeiro, P. F., Mayor, A. M., Moore, R. D. & Edwards, J. K. (2023). Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA, vol. 329, p. 52-62.

 

 

 

Clinical

  1. Pilia, E., Belletti, A., Fresilli, S., Lee, T. C., Zangrillo, A., Finco, G., Landoni, G. & full anticoagulation (2023). The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies. Lung.
  2. Lefebvre, M.-A., Rajda, E., Frenette, C., Paquet, F., Rubin, E., Sleno, H., Stachura, M., Tse, W. & Salvadori, M. I. (2023). Impact of the COVID-19 pandemic on healthcare-associated viral respiratory infections at a tertiary care pediatric hospital. American journal of infection control.
  3. Lam, C., Landry, S., Moussa, G., Sakr, D., Varinot, G., Mousseau, K., Martel, D., Frenette, A. J., Ambaraghassi, G., Rouleau, D., Cantarovich, M., Klein, M. B., Sheehan, N. L. & Lemire, B. (2023). Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review. Transplantation direct, vol. 9, p. e1441.
  4. Sandal, S., Ahn, J. B., Chen, Y., Massie, A. B., Clark-Cutaia, M. N., Wu, W., Cantarovich, M., Segev, D. L. & McAdams-DeMarco, M. A. (2023). Trends in the survival benefit of repeat -kidney transplantation over the past three decades. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
  5. Abrahami, D., Pradhan, R., Yin, H., Yanofsky, R., McDonald, E. G., Bitton, A. & Azoulay, L. (2023). Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study. Gut.
  6. Horton, A., Loban, K., Fortin, M.-C., Charbonneau, S., Nugus, P., Pâquet, M. R., Chaudhury, P., Cantarovich, M. & Sandal, S. (2023). Living Donor Kidney Transplantation in Quebec: A Qualitative Case Study of Health System Barriers and Facilitators. Canadian journal of kidney health and disease, vol. 10, p. 20543581221150675.
  7. Davar, K., Clark, D., Centor, R. M., Dominguez, F., Ghanem, B., Lee, R., Lee, T. C., McDonald, E. G., Phillips, M. C., Sendi, P. & Spellberg, B. (2023). Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV. Open forum infectious diseases, vol. 10, p. ofac706.
  8. Royston, L., Isnard, S., Berini, C. A., Bu, S., Lakatos, P. L., Bessissow, T., Chomont, N., Klein, M., Lebouché, B., de Pokomandy, A., Kronfli, N., Costiniuk, C. T., Thomas, R., Tremblay, C., Boivin, G. & Routy, J.-P. (2023). Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study. BMJ open, vol. 13, p. e067640.
  9. Lee, T. C., Almeida, N., Pelletier, P. & McDonald, E. G. (2023). Comparison of Blood Transfusion Rates Before and After Implementation of a Quality Improvement Initiative for Transfusion Safety and Appropriateness. JAMA network open, vol. 6, p. e2252253.
  10. Shehab, M., Alali, A., Al-Hindawi, A., Alsayegh, A., Aldallal, U., Abdullah, I., Albaghli, A., Alrashed, F., Alfadhli, A. & Bessissow, T. (2022). Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study. Frontiers in medicine, vol. 9, p. 1045661.
  11. Ferru-Clément, R., Boucher, G., Forest, A., Bouchard, B., Bitton, A., Lesage, S., Schumm, P., Lazarev, M., Brant, S., Duerr, R. H., McGovern, D. P. B., Silverberg, M., Cho, J. H., NIDDK IBD Genetics Consortium, iGenoMed Consortium, Ananthakrishnan, A., Xavier, R. J., Rioux, J. D. & Des Rosiers, C. (2023). Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. Inflammatory bowel diseases.
  12. Nguyen, D.-D., Bouhadana, D., Wong, P. & Andonian, S. (2022). What is the prevalence of hepatic steatosis on ultrasonography in patients followed for nephrolithiasis?. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, vol. 16, p. 442-446.
  13. Piyaphane, W., Stoney, R. J., Asgeirsson, H., Appiah, G. D., Díaz-Menéndez, M., Barnett, E. D., Gautret, P., Libman, M., Schlagenhauf, P., Leder, K., Plewes, K., Grobusch, M. P., Huits, R., Mavunda, K., Hamer, D. H. & Chen, L. H. (2023). Health care seeking during travel: an analysis by the GeoSentinel surveillance network of travel medicine providers. Journal of travel medicine.
  14. Patel, D., Senecal, J., Spellberg, B., Morris, A. M., Saxinger, L., Footer, B. W., McDonald, E. G. & Lee, T. C. (2023). Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?. JAC-antimicrobial resistance, vol. 5, p. dlac138.
  15. Lontai, L., Kürti, Z., Gonczi, L., Komlódi, N., Balogh, F., Iliás, Á. & Lakatos, P. L. (2023). Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
  16. Mitjà, O., Reis, G., Boulware, D. R., Spivak, A. M., Sarwar, A., Johnston, C., Webb, B., Hill, M. D., Smith, D., Kremsner, P., Curran, M., Carter, D., Alexander, J., Corbacho, M., Lee, T. C., Hullsiek, K. H., McDonald, E. G., Hess, R., Hughes, M., Baeten, J. M., Schwartz, I., Metz, L., Richer, L., Chew, K. W., Daar, E., Wohl, D. & Dunne, M. (2023). Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials. Clinical and translational science.
  17. Yea, C., Barton, M., Bitnun, A., Morris, S. K., El Tal, T., Ulloa-Gutierrez, R., Brenes-Chacon, H., Yock-Corrales, A., Ivankovich-Escoto, G., Soriano-Fallas, A., Hernandez-de Mezerville, M., Gill, P., Nateghian, A., Aski, B. H., Manafi, A. A., Dwilow, R., Bullard, J., Papenburg, J., Scuccimarri, R., Lefebvre, M.-A., Cooke, S., Dewan, T., Restivo, L., Lopez, A., Sadarangani, M., Roberts, A., Wong, J., Saux, N. L., Bowes, J., Purewal, R., Lautermilch, J., Foo, C., Merckx, J., Robinson, J., Yeh, E. A. & Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) (2023). Neurological involvement in hospitalized children with SARS-CoV-2 infection: a multinational study. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, p. 1-10.
  18. Ma, C., Panaccione, R., Xiao, Y., Khandelwal, Y., Murthy, S. K., Wong, E. C. L., Narula, N., Tsai, C., Peerani, F., Reise-Filteau, M., Bressler, B., Starkey, S. Y., Loomes, D., Sedano, R., Jairath, V. & Bessissow, T. (2022). REMIT-UC: Real World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis. The American journal of gastroenterology.
  19. Díaz-Menéndez, M., Angelo, K. M., Miguel Buckley, R., Bottieau, E., Huits, R., Grobusch, M. P., Gobbi, F. G., Asgeirsson, H., Duvignaud, A., Norman, F. F., Javelle, E., Epelboin, L., Rothe, C., Chappuis, F., Martinez, G. E., Popescu, C., Camprubí-Ferrer, D., Molina, I., Odolini, S., Barkati, S., Kuhn, S., Vaughan, S., McCarthy, A., Lago, M., Libman, M. D. & Hamer, D. H. (2022). Dengue outbreak among travellers returning from Cuba-GeoSentinel surveillance network, January-September 2022. Journal of travel medicine.
  20. Wetwittayakhlang, P., Gonczi, L., Lakatos, L., Kurti, Z., Golovics, P., Pandur, T., David, G., Erdelyi, Z., Szita, I. & Lakatos, P. L. (2022). Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras - Results from Western Hungarian Population-based Inception Cohort between 1977-2020. Journal of Crohn's & colitis.
  21. Wetwittayakhlang, P., Golovics, P. A., Khoury, A. A., Ganni, E., Hahn, G. D., Cohen, A., Wyse, J., Bradette, M., Bessissow, T., Afif, W., Wild, G., Bitton, A. & Lakatos, P. L. (2022). Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study. Journal of gastrointestinal and liver diseases : JGLD, vol. 31, p. 403-410.
  22. Sandal, S., Schiller, I., Dendukuri, N., Robert, J.-T., Katergi, K., Alam, A., Cantarovich, M., Fiore, J. F., Suri, R. S., Landsberg, D., Weber, C. & Fortin, M.-C. (2022). Identifying Modifiable System-Level Barriers to Living Donor Kidney Transplantation. Kidney international reports, vol. 7, p. 2410-2420.
  23. Harrison, L. B., Bergeron, G., Cadieux, G., Charest, H., Fafard, J., Levade, I., Blais, A. C., Huchet, E., Trottier, B., Vlad, D., Szabo, J., Thomas, R., Poulin, S., Greenaway, C., Zaharatos, G. J., Oughton, M., Chakravarti, A., Pilarski, R., Bui-Nguyen, A., Benomar, K., Libman, M. D., Vinh, D. C., Duggan, A. T., Graham, M., Klein, M. B. & Barkati, S. (2023). Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak. Annals of internal medicine, vol. 176, p. 67-76.
  24. Shehab, M., Alrashed, F., Charabaty, A. & Bessissow, T. (2022). Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysis. Journal of the Canadian Association of Gastroenterology, vol. 5, p. 287-296.
  25. Mahajna, H., Verstockt, B., Bergemalm, D., Castiglione, F., Rodríguez-Moranta, F., Savarino, E. V., Hoentjen, F., Bessissow, T., Pokryszka, J., Cremer, A., Eder, P., Truyens, M., Yerushalmy-Feler, A., Garcia, M. J. & Kopylov, U. (2022). Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series. Journal of Crohn's & colitis.

 

McGill

  1. D'Iorio, M. & Dewar, K. (2023). Replication-associated inversions are the dominant form of bacterial chromosome structural variation. Life science alliance, vol. 6.
  2. Xu, Z., Choi, J.-H., Dai, D. L., Luo, J., Ladak, R. J., Li, Q., Wang, Y., Zhang, C., Wiebe, S., Liu, A. C. H., Ran, X., Yang, J., Naeli, P., Garzia, A., Zhou, L., Mahmood, N., Deng, Q., Elaish, M., Lin, R., Mahal, L. K., Hobman, T. C., Pelletier, J., Alain, T., Vidal, S. M., Duchaine, T., Mazhab-Jafari, M. T., Mao, X., Jafarnejad, S. M. & Sonenberg, N. (2022). SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation. Proceedings of the National Academy of Sciences of the United States of America, vol. 119, p. e2204539119.
  3. Markarian, N. M., Galli, G., Patel, D., Hemmings, M., Nagpal, P., Berghuis, A. M., Abrahamyan, L. & Vidal, S. M. (2022). Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. Frontiers in microbiology, vol. 13, p. 933983.
  4. Béliveau, C., Gagné, P., Picq, S., Vernygora, O., Keeling, C. I., Pinkney, K., Doucet, D., Wen, F., Johnston, J. S., Maaroufi, H., Boyle, B., Laroche, J., Dewar, K., Juretic, N., Blackburn, G., Nisole, A., Brunet, B., Brandao, M., Lumley, L., Duan, J., Quan, G., Lucarotti, C. J., Roe, A. D., Sperling, F. A. H., Levesque, R. C. & Cusson, M. (2022). The Spruce Budworm Genome: Reconstructing the Evolutionary History of Antifreeze Proteins. Genome biology and evolution, vol. 14.
  5. Mindt, B. C., Krisna, S. S., Duerr, C. U., Mancini, M., Richer, L., Vidal, S. M., Gerondakis, S., Langlais, D. & Fritz, J. H. (2021). The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation. Frontiers in immunology, vol. 12, p. 664218.
  6. Abed, J. Y., Déraspe, M., Bérubé, È., D'Iorio, M., Dewar, K., Boissinot, M., Corbeil, J., Bergeron, M. G. & Roy, P. H. (2021). Complete Genome Sequences of Klebsiella michiganensis and Citrobacter farmeri, KPC-2-Producers Serially Isolated from a Single Patient. Antibiotics (Basel, Switzerland), vol. 10.
  7. Mancini, M., Charbonneau, B., Langlais, D. & Vidal, S. M. (2021). The c-Rel transcription factor limits early interferon and neuroinflammatory responses to prevent herpes simplex encephalitis onset in mice. Scientific reports, vol. 11, p. 21171.
  8. Cavestri, C., Savard, P., Fliss, I., Emond-Rhéault, J.-G., Hamel, J., Kukavica-Ibrulj, I., Boyle, B., Daigle, F., Malo, D., Bekal, S., Harris, L. J., Levesque, R. C., Goodridge, L. & LaPointe, G. (2022). Salmonella enterica subsp. enterica virulence potential can be linked to higher survival within a dynamic in vitro human gastrointestinal model. Food microbiology, vol. 101, p. 103877.
  9. Charlier, J., Nadon, R. & Makarenkov, V. (2021). Accurate deep learning off-target prediction with novel sgRNA-DNA sequence encoding in CRISPR-Cas9 gene editing. Bioinformatics (Oxford, England).
  10. Xu, G., van Bruggen, R., Gualtieri, C. O., Moradin, N., Fois, A., Vallerand, D., De Sa Tavares Russo, M., Bassenden, A., Lu, W., Tam, M., Lesage, S., Girouard, H., Avizonis, D. Z., Deblois, G., Prchal, J. T., Stevenson, M., Berghuis, A., Muir, T., Rabinowitz, J., Vidal, S. M., Fodil, N. & Gros, P. (2020). Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia. Cell reports, vol. 32, p. 108170.
  11. Emond-Rheault, J.-G., Hamel, J., Jeukens, J., Freschi, L., Kukavica-Ibrulj, I., Boyle, B., Tamber, S., Malo, D., Franz, E., Burnett, E., Daigle, F., Arya, G., Sanderson, K., Wiedmann, M., Slawson, R. M., Weadge, J. T., Stephan, R., Bekal, S., Gruenheid, S., Goodridge, L. D. & Levesque, R. C. (2020). The Salmonella enterica Plasmidome as a Reservoir of Antibiotic Resistance. Microorganisms, vol. 8.
  12. Cavalcanti, G. S., Wasserscheid, J., Dewar, K. & Shikuma, N. J. (2020). Complete Genome Sequences of Two Marine Biofilm Isolates, Leisingera sp. nov. Strains 201A and 204H, Novel Representatives of the Roseobacter Group. Microbiology resource announcements, vol. 9.
  13. Crouse, A., Schramm, C., Emond-Rheault, J.-G., Herod, A., Kerhoas, M., Rohde, J., Gruenheid, S., Kukavica-Ibrulj, I., Boyle, B., Greenwood, C. M. T., Goodridge, L. D., Garduno, R., Levesque, R. C., Malo, D. & Daigle, F. (2020). Combining Whole-Genome Sequencing and Multimodel Phenotyping To Identify Genetic Predictors of Salmonella Virulence. mSphere, vol. 5.
  14. Mancini, M. & Vidal, S. M. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annual review of immunology, vol. 38, p. 511-539.
  15. Bayega, A., Djambazian, H., Tsoumani, K. T., Gregoriou, M.-E., Sagri, E., Drosopoulou, E., Mavragani-Tsipidou, P., Giorda, K., Tsiamis, G., Bourtzis, K., Oikonomopoulos, S., Dewar, K., Church, D. M., Papanicolaou, A., Mathiopoulos, K. D. & Ragoussis, J. (2020). De novo assembly of the olive fruit fly (Bactrocera oleae) genome with linked-reads and long-read technologies minimizes gaps and provides exceptional Y chromosome assembly. BMC genomics, vol. 21, p. 259.
  16. Péan, N., Le Lay, A., Brial, F., Wasserscheid, J., Rouch, C., Vincent, M., Myridakis, A., Hedjazi, L., Dumas, M.-E., Grundberg, E., Lathrop, M., Magnan, C., Dewar, K. & Gauguier, D. (2020). Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto-Kakizaki rats improves glucose homeostasis through enhanced FXR signalling. Diabetologia, vol. 63, p. 1223-1235.
  17. Kennedy, J. M., Georges, A., Bassenden, A. V., Vidal, S. M., Berghuis, A. M., Taniuchi, I., Majewski, J., Lathrop, M., Behr, M. A., Langlais, D. & Gros, P. (2020). ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis. Infection and immunity, vol. 88.
  18. Hebert, F. O., Freschi, L., Blackburn, G., Béliveau, C., Dewar, K., Boyle, B., Gundersen-Rindal, D. E., Sparks, M. E., Cusson, M., Hamelin, R. C. & Levesque, R. C. (2019). Expansion of LINEs and species-specific DNA repeats drives genome expansion in Asian Gypsy Moths. Scientific reports, vol. 9, p. 16413.
  19. Zhang, J., Teh, M., Kim, J., Eva, M. M., Cayrol, R., Meade, R., Nijnik, A., Montagutelli, X., Malo, D. & Jaubert, J. (2019). A Loss-of-Function Mutation in the Integrin Alpha L (Itgal) Gene Contributes to Susceptibility to Salmonella enterica Serovar Typhimurium Infection in Collaborative Cross Strain CC042. Infection and immunity, vol. 88.
  20. Chehboun, S., Leiva-Torres, G. A., Charbonneau, B., Eveleigh, R., Bourque, G. & Vidal, S. M. (2020). A point mutation in the linker domain of mouse STAT5A is associated with impaired NK-cell regulation. Genes and immunity, vol. 21, p. 136-141.
  21. Desloges, I., Taylor, J. A., Leclerc, J.-M., Brannon, J. R., Portt, A., Spencer, J. D., Dewar, K., Marczynski, G. T., Manges, A., Gruenheid, S., Le Moual, H. & Thomassin, J.-L. (2019). Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates. MicrobiologyOpen, vol. 8, p. e915.
  22. Yarborough, M., Nadon, R. & Karlin, D. G. (2019). Four erroneous beliefs thwarting more trustworthy research. eLife, vol. 8.
  23. Yuki, K. E., Marei, H., Fiskin, E., Eva, M. M., Gopal, A. A., Schwartzentruber, J. A., Majewski, J., Cellier, M., Mandl, J. N., Vidal, S. M., Malo, D. & Dikic, I. (2019). CYRI/FAM49B negatively regulates RAC1-driven cytoskeletal remodelling and protects against bacterial infection. Nature microbiology, vol. 4, p. 1516-1531.
  24. Minerbi, A., Gonzalez, E., Brereton, N. J. B., Anjarkouchian, A., Dewar, K., Fitzcharles, M.-A., Chevalier, S. & Shir, Y. (2019). Altered microbiome composition in individuals with fibromyalgia. Pain, vol. 160, p. 2589-2602.
  25. Železnjak, J., Lisnić, V. J., Popović, B., Lisnić, B., Babić, M., Halenius, A., L'Hernault, A., Roviš, T. L., Hengel, H., Erhard, F., Redwood, A. J., Vidal, S. M., Dölken, L., Krmpotić, A. & Jonjić, S. (2019). The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors. The Journal of experimental medicine, vol. 216, p. 1809-1827.